- New framework forecasts risk for 18 obesity-related complications: Study
- US drug spending to surpass $1 trillion in 2026: ASHP
- Baptist Health Arkansas hospital makes more cuts, affecting 150 roles
- 5 revenue cycle leaders to know
- Health systems hit build vs. buy inflection point
- Oracle in the last 30 days
- AI’s role in combating antibiotic resistance: 4 things to know
- Tenet posts 24.1% margin in Q1 after Conifer deal: 6 things to know
- How Emory is using da Vinci digital surgery tools to train the next generation: 3 takeaways
- 12 hospital executives’ thank-you notes to nurses
- Northwestern opens $15M endoscopy center
- Which physicians are the most pessimistic, optimistic about their future? A breakdown
- CRNA group honors Oregon congresswoman
- VCU Health breaks ground on outpatient heart center
- Sleep and Anxiety Medications in Pregnancy Appear to Pose Little Harm
- Massachusetts cardiology group joins UMass division
- Trump's Medicaid Work Mandate Debuting in Nebraska to Much Dismay
- Prehabilitation Slashes Post-Op Complications By Half, Review Says
- Nasal Spray Flu Vaccines Create 'Battlefield' In Adults' Noses
- Understanding Emotions Could Be Key To Quelling Chronic Pain
- Meth Caused 1 In 6 Heart Attacks Over A Decade, Study Finds
- When Natural Disasters Strike, Another Crisis Hits Those Recovering From Opioid Addiction
- States Rush To Figure Out How To Enforce Trump’s Medicaid Work Requirements
- Cigna posts $1.65B in profit in Q1 earnings beat
- Amarox recalls batch of antidepressants in UK over packaging mix-up
- Bayer earns FDA untitled letter for Nubeqa's 'attention-grabbing visuals'
- Merck bats for heart disease awareness with new baseball-inspired campaign
- Avalyn heads to Nasdaq with oversized $300M IPO to fund reformulated respiratory drugs
- Europe’s drug regulator sets up new group to counter vaccine hesitancy
- Maine law increases oversight of healthcare transactions: 6 notes for dental leaders
- Align Technology sees 6.2% increase in Q1 revenue: 7 notes
- Aidoc banks $150M backed by Goldman Sachs to scale clinical AI foundation model
- 8 behavioral healthcare M&A deals in 2026
- Maryland autism therapy provider expands in-home services in Colorado
- ‘There are no easy solutions’: What dental leaders told us in April
- Connecticut House passes bill authorizing at-home dental hygiene visits
- Delaware physician to pay $180K to settle fraud allegations
- Tennessee specialist group joins Maury Regional Medical Group
- New Jersey ASC performs robotic spine surgery milestone
- Aviation, hospitality and the NFL: What dentistry can learn from other industries
- Virginia expands noncompete limits for terminated employees
- Over half of dental professionals dealing with burnout: Report
- Jefferson Health lands $1.7M grant for hypertension care
- 22 behavioral health executive moves to know
- The ‘significant opportunity’ Talkspace will bring to UHS
- Dental’s new cash-pay anesthesia opportunity
- Healthcare costs remain a top concern for voters as midterms loom: KFF
- UHS-owned behavioral health facility to lay off 648 employees
- Novartis rounds out $23B US investment push with plans for North Carolina API plant
- Teladoc Health reports strong momentum behind BetterHelp insurance shift, CEO says
- Georgia Southern University to begin construction of new dental school
- AI Tool May Help Identify ADHD in Kids Long Before Typical Diagnosis
- Tennessee dental school to open clinic in Kentucky
- Federal autism committee outlines policy, care gaps in HHS letter
- Tennessee provider expands virtual behavioral health urgent care
- Chicago invests $16.2M in mental health, street psychiatry program
- US suicide rate declines 2%: 5 things to know
- Viz.ai partners with National Rural Health Association to expand AI understanding, access to rural hospitals
- FDA Moves to Real-Time Clinical Trial Patient Monitoring, Faster Drug Review
- AstraZeneca CEO's conservative MFN model excludes reference markets from forecast
- With Austedo at helm, Teva's impressive innovative drug sales signal company's successful metamorphosis
- Universal Health Services' Q1 2026 earnings growth dampened by volume hits
- AbbVie outlines Skyrizi defense against new J&J plaque psoriasis rival Icotyde
- Regeneron's quarterly sales of Eylea drop below $1B for the first time in 8 years
- Only 1 in 4 employers able to ‘absorb’ increasing health benefit costs without impacting business
- Dementia Screening Safe For Families, Trial Finds
- Online Program Soothes Post-Trauma Stress In Injured Children
- Mental Defeat Can Worsen Chronic Pain, Researchers Say
- Pooled Umbilical Cord Blood Boosts Stem Cell Transplant Success, Trial Finds
- New GSK CEO’s first quarter boosted by Shingrix surge as Exdensur stumbles in switch trial
- AstraZeneca restarts £300M investment in UK, but Merck not budging
- Chiesi lays out $1.9B to bolster rare disease offerings with KalVista buyout
- US drugmaker’s reputations shift quickly amid political pressures, job cuts: survey
- Saving Lives by Changing Lives: The Next Frontier in Suicide Prevention
- Trump’s Medicaid Work Mandate Debuting in Nebraska to Much Dismay
- Pfizer looks to jump start Elrexfio with topline win in second-line myeloma
- The push to expand access to emergency contraception
- Humana pulls back the curtain on planning for 2027 MA bids
- Lawmakers introduce bill to expand mental health clinics
- What 5 dentists would do differently in their careers
- On Capitol Hill, health system CEOs agree to 'rational reworking' of site-neutral payments
- Novartis CEO calls for 'complete rethink' of Europe's drug pricing policies
- Secret to Surviving 'Perfect Mom' Posts on Social Media Revealed
- Pfizer’s victory in delaying Vyndamax generics is mixed bag for BridgeBio: analysts
- Remarks at the Small Business Capital Formation Advisory Committee Meeting
- Getting All Your Ducks in a Row to IPO: Remarks at the Small Business Capital Formation Advisory Committee Meeting
- Remarks to the Small Business Capital Formation Advisory Committee
- FDA flags concerns for AstraZeneca's camizestrant, Truqap ahead of advisory committee meeting
- CDC Warns of Antibiotic-Resistant Salmonella in Backyard Flocks
- Listen to the Latest ‘KFF Health News Minute’
- AI-driven coding platform Arintra rolls out new documentation improvement capabilities
- Florida Delays Children's Health Insurance Expansion as Uninsured Rate Rises
- Interoperability was Never the Finish Line in Healthcare
- Interoperability was Never the Finish Line in Healthcare
- IKS Health to acquire TruBridge in $557M deal
- FDA turns up heat on Amgen, proposing to rescind approval of Tavneos
- Rocket sells priority review voucher for $180M after Kresladi gene therapy approval
- Big companies position themselves for payday from $50B federal rural health fund
- AZ's Breztri nabs FDA asthma nod, adding fuel to blockbuster launch
- Haleon scores branding goal with star-studded soccer offensive
- Daylight Saving Time Fails to Boost Daily Steps, Study Finds
- Metabolic Syndrome Tied To Cancer Risk
- Mail-In Colon Cancer Test Kits Offer Affordable Screening
- U.S. Dentists Still Overprescribing Opioids Compared To Other Nations, Puerto Rico
- Novartis stands by $5B Pluvicto goal despite European regulatory setback, bispecific competition
- Big Companies Position Themselves for Payday From $50B Federal Rural Health Fund
- An Urgent Care Treated Her Allergic Reaction. An ER Monitored Her — For $6,700.
- Centene swings to $1.5B profit as Medicaid business improves even as ACA membership falls by 2 million
- CCS deploys enterprise-wide agentic AI across chronic care operations
- Utah Medical Licensing Board urges state to shut down Doctronic AI prescribing pilot
- Estrogen Patch Shortages Likely Driven By Empowered Women Seeking Relief, Expert Says
- GSK's Tesaro unit dealt pre-trial blow in Jemperli feud with AnaptysBio
- Medical professional liability premiums rise for 7th straight year
- UChicago Medicine, Artisight partner on system-wide rollout of smart hospital platform
- Solace Health expands care navigation services to commercially insured patients
- First Gene Therapy for Genetic Hearing Loss, Otarmeni, Gains FDA Approval
- CMS Extends Medicare's Short-Term Bridge Program for GLP-1 Obesity Drug Coverage
- Humana's CenterWell, Mark Cuban Cost Plus Drugs partner to tackle employers' drug costs
- AMA urges lawmakers to implement stronger safeguards for AI chatbots in mental health
- Blood Glucose Monitors Improve Control Among Type 2 Diabetes Patients
- Regaining Weight After Quitting Your GLP-1 Drug? A Simple Procedure Might Help, Study Says
- Late-Night Noshing Could Contribute To Stress-Related Bathroom Problems
- New Treatment Targets Unaddressed Major Symptom Of Depression Through Joy, Pleasure and Purpose
- The Help That Many Older Americans Need Most
- Florida Delays Children’s Health Insurance Expansion as Uninsured Rate Rises
- UnityAI builds out agentic AI for staffing operations to match outpatient clinicians with patient demand
- Why Pricier Olive Oil May Be Better For Your Brain
- Your Internal Signal to Stop Eating is More Complex Than Previously Thought
- Gounder Culls the News, From Ticks and AI to Who Might Lead CDC
- FDA Accelerates Action on Treatments for Serious Mental Illness Following Executive Order
- Green Lighting Capital Formation: Remarks at the SEC International Institute on Capital Formation
- With ‘lessons learned,’ Kite prepares to hit the ground running as next-gen CAR-T decision looms
- Former Tobacco Executive Takes CDC Role
- New Plan Could Speed Medicare Coverage for Innovative Devices
- Heated Socks Sold at Costco Recalled After Burn Reports
- First Measles Case of the Year Reported in New Jersey
- CMS, FDA Announce RAPID Coverage Pathway to Accelerate Device Reimbursement
- CMS, FDA Announce RAPID Coverage Pathway to Accelerate Device Reimbursement
- Does Motherhood Shield You From Stroke?
- These Fun Pursuits Help Middle-Aged Folks Protect Brain Health, Study Finds
- New Guidelines Highlight Behavioral Therapy For Insomnia
- Playing Pretend Provides Unexpected Benefits For Growing Kids
- New Survey Estimates 8 Million Americans Used Psilocybin in 2024
- Eye Photos Might Offer Early Warning Of Chronic Health Problems, AI Study Finds
- A look at payers' attitudes toward specialty drug management
- 988 Hotline Leads to Fewer Suicides Among Young People, Study Finds
- Opening Remarks at the 32nd Annual International Institute for Securities Market Growth and Development
- Keynote Remarks at The Economic Club of Washington
- Rethinking Prior Authorization for Better Outcomes
- Statement on the Amendments to Form PF
LARA's licensing process is heavily weighted on the entry side, with very little real supervision after licensing. Dr. Farid T. Fata should never have been licensed in Michigan, and his license should have been revoked well before his arrest in 2013.
An experienced oncology nurse, Angela Swantek, interviewed at Dr. Fata's Michigan Hematology-Oncology (MHO) in 2010 and saw practices that were "plain wrong". Ms. Swantek was convinced that MHO was drugging patients solely to bill their insurance companies for extravagant fees. She filed a complaint with LARA, but got no response until 2011, when LARA sent her a form letter saying that there was no evidence to support an investigation into Fata. An MHO office manager, George Karadsheh, echoed Ms. Swantek's allegations in 2013, finally leading to Dr. Fata's arrest:
https://thecinemaholic.com/farid-fata-where-is-the-fraudster-now/
Farid Fata: Where is the Fraudster Now?
By Sounak Sengupta - June 17, 2023NBC’s ‘Dateline: Do No Harm’ follows the criminal antiques of fraudster, Dr. Farid Fata, as he was convicted of medical malpractice and other charges in August 2013 in Michigan. Rather than treating or easing the suffering of his cancer patients, he administered a combination of chemical infusions and injections with potentially harmful and deadly side effects for his financial benefit. So, how was Farid caught, and where is he now? Let’s find out.
Who is Farid Fata?
Farid T. Fata was born to a Melkite Catholic family in Lebanon in 1965. He secured a medical degree in his native country in 1992 before migrating to the United States to pursue a career in medical science. He served a residency at Maimonides Medical Center in Brooklyn, New York, from 1993 to 1996 and then as a fellow in hematology-oncology at Memorial Sloan Kettering Cancer Center in Manhattan until 1999. Farid worked as an attending physician at Geisinger Medical Center in Danville, Pennsylvania, from 2000 to 2003.
He opened his solely owned practice, Michigan Hematology-Oncology (MHO), at 543 North Main Street in 2003 in Rochester Hills, Michigan. What started as a small, single physician office expanded over the following decade and grew to six more locations — Clarkston, Bloomfield Hills, Lapeer, Sterling Heights, Troy, and Oak Park. Farid became a naturalized U.S. citizen in April 2009. By the time he was arrested in 2013, MHO had 16,000 historical patients and 1,700 current patients — the vast majority of whom belonged to Farid.
Court records underlined how he accomplished this astonishing growth using several means. His business documents and employee testimonies state Farid was seeing as many as 50-60 patients per day, scheduled in eight-minute increments. He employed non-licensed physicians with medical degrees from foreign countries to work them up before he saw them for five-ten minutes, billing at the two highest levels for office visits. Patients waited for hours at a time before they were ushered in.
According to an oncology supply company representative supplying most of his drugs, Farid worked on a plan to compete with large practices. His medicine orders skyrocketed in a year to over $7 million, then $16 million. He ordered in bulk at the end of quarters to reach the threshold for contractual discounts. Reports stated an average doctor in an oncology practice purchases approximately $1.5 million of drugs in a given year. However, when he was arrested, MHO bought $45 million for only three doctors.
A sentencing memorandum stated how Farid expanded his businesses to include a radiation treatment center, Michigan Radiation Institute (MRI); an in-house pharmacy at MHO’s Rochester Hills location, Vital Pharmacare (Vital); a diagnostic testing facility, United Diagnostics; and a charity located at MHO and staffed by social workers and grant writers, Swan for Life. Farid specialized in treating blood cancer and earned a sterling reputation as one of the best cancer specialists in the Detroit area.
According to the episode, he created a niche for himself with his aggressive treatment procedures that involved giving higher doses of chemotherapy drugs more frequently — he termed it the “European protocol.” Farid’s erstwhile wife, Samar, helped run the business side of his practice as Chief Executive Officer and Chief Financial Officer of his companies. According to an ensuing investigation, the federal officers termed Farid the most egregious fraudster in the history of this country.
Where is Farid Fata Now?
His misdemeanors were not solely limited to the millions of dollars he stole but also the harm he inflicted on more than 500 patients. Some of Farid’s misdemeanors include deliberately misdiagnosing patients with multiple myeloma, administering unrequired chemotherapy to patients, lying to them about the availability of alternative treatments, and ordering infusion times increased beyond what was medically necessary or advisable purely to increase his reimbursement.
The episode showed how there had been signs about his malpractice, which included a civil suit filed by a patient in 2007 and a veteran oncology nurse complaining to the state authorities in 2010. However, Farid’s schemes began to unravel in July 2013 when one of his 54-year-old patients, Monica Flagg, broke her leg and went to a suburban Detroit-area hospital for treatment. Farid, who had diagnosed her with multiple myeloma, was on vacation in Lebanon, and one of his doctors, Soe Maunglay, attended to Monica at MHO.
Soe could find no indication for the chemotherapy and supportive care medications. Reports stated he was already on notice after catching Farid lying about the clinic’s enrollment in a professional quality program. Suspicious, Soe began investigating some of Farid’s other cases, which included excessive use of rituximab and IVIG. During his probe, he contacted Farid’s practice manager, George Karadsheh, whose inspection supported Soe’s suspicions. George went to the Department of Justice and was interviewed on August 2, 2013.
The federal agents interviewed several staff members of MHO and corroborated the claims made by the whistleblowers — George and Soe. They arrested Farid and charged him with 19 counts of healthcare fraud and other crimes. Originally held on a $170,000 bond, the federal authorities discovered he and his wife had assets of $9 million not yet seized. Fearing him a flight risk, a federal judge raised Farid’s bond to $9 million. The Federal Bureau of Investigation confiscated thousands of medical charts.
They amassed evidence that he had used dishonest measures to trick the patients’ insurance companies and Medicare into paying $34 million in fraudulent and unnecessary claims. The officers also discovered that Farid took kickbacks from two local hospices and poured Medicare and private insurance proceeds into his diagnostic testing facility. They filed a 23-count indictment charging him with healthcare fraud, conspiracy to take and receive kickbacks, money laundering, and unlawfully procuring naturalization. Facing a maximum of 175 years in prison and the prospect of losing citizenship, Farid decided to take a plea deal.
He pled guilty in September 2014 to 16 federal charges — 13 counts of health care fraud, two counts of money laundering, and one count of conspiring to pay and receive kickbacks and cash payments for referring patients to a particular hospice and home health care company. He was sentenced to 45 years in federal prison and agreed to forfeit millions of dollars in assets to pay restitution to former patients or their families, approximately $17.6 million. The 58-year-old is incarcerated at Federal Correctional Institution, Williamsburg in South Carolina, and will not be released before December 2050.
What a saga. Who knew charisma/mystique could completely deceive so many people about their own health?
I also wonder how much he skewed regional/state cancer statistics. Is his fraud the reason Michigan has "hot spots" for certain types of cancer?
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.















